StockGlow

Silence Therapeutics plc (SLNCF)

Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.

$1.50+0.00%Healthcare
Compare SLNCF with
StockGlow Score
15
Bearish
BearishBullish
1 year ago-6.3%

The outlook

Silence Therapeutics plc currently reads as bearish based on below its 50- & 200-day averages, 28% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range28% of the way from its 52-week low to high
Market cap
$212.6M
52-wk high
$2.63
52-wk low
$1.06
50-day avg
$1.52
200-day avg
$1.75
Trailing P/E
—

Similar stocks

PTCHFPureTech Health plc$1.53+0.00%SLNSilence Therapeutics plc$11.23-3.36%PHGUFPharming Group N.V.$1.30+0.00%OXBDFOxford Biomedica plc$8.00+0.00%SPHRYStarpharma Holdings Limited$5.20+0.00%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy